 SAN DIEGO-- BUSINESS WIRE --Arcturus Therapeutics Holdings Inc. the Company, Arcturus, Nasdaq: ARCT, a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will present at the Annual J.P. Morgan Healthcare Conference in San Francisco, on Wednesday, January 11, 2023, at 9:00 a.m. Pacific Time. 